Trousseau's syndrome: Multiple definitions and multiple mechanisms, Blood, vol.110, pp.1723-1729, 2007. ,
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences, Thromb. Res, vol.139, pp.65-76, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01455290
Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells, Blood, vol.105, pp.178-185, 2005. ,
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis, Cancer Cell, vol.20, pp.576-590, 2011. ,
Platelets guide the formation of early metastatic niches, Proc. Natl. Acad. Sci, vol.111, pp.3053-3061, 2014. ,
Effects of platelets on cancer progression, Thromb. Res, vol.164, pp.40-47, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02060300
Antimetastatic effects associated with platelet reduction, Proc. Natl. Acad. Sci, vol.61, pp.46-52, 1968. ,
Role of platelets in tumor cell metastases, Ann. Intern. Med, vol.95, pp.636-641, 1981. ,
Paraneoplastic thrombocytosis in gastrointestinal cancer, Platelets, vol.27, pp.269-275, 2016. ,
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study, Cancer, vol.104, pp.2822-2829, 2005. ,
Poor prognosis associated with thrombocytosis in patients with gastric cancer, Ann. Surg. Oncol, vol.9, pp.287-291, 2002. ,
Thrombocytosis as a prognostic factor in endometrial carcinoma, Gynecol. Oncol, vol.70, pp.210-214, 1998. ,
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer, Acta Oncol, vol.54, pp.971-978, 2015. ,
Platelet count and survival in patients with colorectal cancer-A preliminary study, Thromb. Haemost, vol.79, pp.916-918, 1998. ,
Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma, BJU Int, vol.87, pp.715-716, 2001. ,
Thrombocytosis: Platelet kinetics in neoplasia, J. Lab. Clin. Med, vol.84, pp.615-619, 1974. ,
Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients, Platelets, vol.26, pp.138-142, 2015. ,
Thrombocytosis in patients with tumors producing colony-stimulating factor, Blood, vol.80, pp.2052-2059, 1992. ,
Paraneoplastic thrombocytosis in ovarian cancer, N. Engl. J. Med, vol.366, pp.610-618, 2012. ,
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: Role in inflammatory thrombocytosis, Blood, vol.98, pp.2720-2725, 2001. ,
Production of thrombopoietin by human carcinomas and its novel isoforms, Blood, vol.94, pp.1952-1960, 1999. ,
Thrombopoietin-producing hepatocellular carcinoma, Intern. Med, vol.42, pp.730-734, 2003. ,
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors, Blood, vol.86, pp.3353-3363, 1995. ,
Regulation of Hematopoiesis by Microvascular Endothelium, Leuk. Lymphoma, vol.27, pp.375-386, 1997. ,
Secretion of cytokines (interleukins-1 alpha, -3, and -6 and granulocyte-macrophage colony-stimulating factor) by normal human bone marrow megakaryocytes, Blood, vol.85, pp.685-691, 1995. ,
Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells, Exp. Hematol, vol.30, pp.450-459, 2002. ,
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets, Proc. Natl. Acad. Sci, vol.94, pp.663-668, 1997. ,
Platelet phenotype changes associated with breast cancer and its treatment, Platelets, vol.27, pp.703-711, 2016. ,
Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor, Blood, vol.101, pp.1316-1323, 2003. ,
Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor, Int. J. Hematol, vol.62, pp.203-215, 1995. ,
Modulation of megakaryocytopoiesis by human basic fibroblast growth factor, Blood, vol.83, pp.2126-2132, 1994. ,
Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients, Thromb. Res, vol.129, pp.6-9, 2012. ,
Thrombospondin-1: A unique marker to identify in vitro platelet activation when monitoring in vivo processes, J. Thromb. Haemost, vol.8, pp.1809-1819, 2010. ,
Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers, Exp. Mol. Med, vol.44, pp.36-44, 2012. ,
Elevated serum soluble CD40 ligand in cancer patients may play an immunosuppressive role, Blood, vol.120, pp.3030-3038, 2012. ,
Elevated plasma levels of beta-thromboglobulin in breast cancer, Oncology, vol.43, pp.208-211, 1986. ,
Serum platelet factor 4 is an independent predictor of survival and venous thromboembolism in patients with pancreatic adenocarcinoma, Cancer Epidemiol. Biomark. Prev, vol.19, pp.2605-2610, 2010. ,
Kemona-Chetnik, I. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer, Neoplasma, vol.50, pp.262-265, 2003. ,
Association of platelet activation markers with cancer-associated venous thromboembolism, Platelets, vol.27, pp.80-85, 2016. ,
Procoagulant mechanisms in tumour cells, Best Pract. Res. Clin. Haematol, vol.22, pp.49-60, 2009. ,
Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo, J. Clin. Investig, vol.81, pp.1012-1019, 1988. ,
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal, J. Clin. Investig, vol.126, pp.1885-1896, 2016. ,
Human platelet-tumor cell interactions vary with the tumor cell lines, Invasion Metastasis, vol.6, pp.321-334, 1986. ,
Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine, Thromb. Haemost, vol.55, pp.333-337, 1986. ,
Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets, Br. J. Haematol, vol.87, pp.763-772, 1994. ,
URL : https://hal.archives-ouvertes.fr/hal-00313722
Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: Role of receptor glycoproteins, Br. J. Pharmacol, vol.141, pp.241-252, 2004. ,
Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines, J. Cancer Res. Clin. Oncol, vol.122, pp.735-744, 1996. ,
Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2, FEBS Lett, vol.580, pp.3368-3374, 2006. ,
Examination of thromboxane synthase as a prognostic factor and therapeutic target in non-small cell lung cancer, Mol. Cancer, vol.10, 2011. ,
Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth, Mod. Pathol, vol.18, pp.221-227, 2005. ,
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer, Cancer Res, vol.65, pp.11581-11587, 2005. ,
Differential expression of thromboxane synthase in prostate carcinoma: Role in tumor cell motility, Am. J. Pathol, vol.164, pp.429-439, 2004. ,
Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation, Prostaglandins Leukot. Essent. Fatty Acids, vol.68, pp.55-59, 2003. ,
A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis, Biochem. Biophys. Res. Commun, vol.267, pp.245-251, 2000. ,
The many roles of CD40 in cell-mediated inflammatory responses, Immunol. Today, vol.17, pp.487-492, 1996. ,
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, vol.391, pp.591-594, 1998. ,
Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40, J. Immunol, vol.142, pp.562-567, 1989. ,
Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis, Clin. Exp. Metastasis, vol.26, pp.829-837, 2009. ,
Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes, Int. J. Cancer, vol.43, pp.786-794, 1989. ,
Expression of CD154 on renal cell carcinomas and effect on cell proliferation, motility and platelet-activating factor synthesis, Int. J. Cancer, vol.100, pp.654-661, 2002. ,
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40, Blood, vol.98, pp.1047-1054, 2001. ,
Beyond hemostasis: The role of platelets in inflammation, malignancy and infection, Cardiovasc. Hematol. Disord. Drug Targets, vol.8, pp.99-117, 2008. ,
CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation, Circ. Res, vol.92, pp.1041-1048, 2003. ,
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer, Clin. Cancer Res, vol.7, pp.691-703, 2001. ,
CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors, Int. J. Cancer, vol.92, pp.589-599, 2001. ,
De Wolf-Peeters, C. CD40 is a prognostic marker in primary cutaneous malignant melanoma, Am. J. Pathol, vol.149, pp.1953-1961, 1996. ,
CD40/CD40L system and vascular disease, Intern. Emerg. Med, vol.2, pp.256-268, 2007. ,
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: Regulation by nitric oxide, Cancer Res, vol.61, pp.376-382, 2001. ,
Platelet aggregation-induced by caco-2 cells: Regulation by matrix metalloproteinase-2 and adenosine diphosphate, J. Pharmacol. Exp. Ther, vol.317, pp.739-745, 2006. ,
Tumor cell-platelet aggregation: Induced by cathepsin B-like proteinase and inhibited by prostacyclin, Science, vol.217, pp.540-542, 1982. ,
Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer-Molecularly distinct behavior of cathepsin K in breast cancer, BMC Cancer, vol.16, 2016. ,
Regulation of tissue factor gene expression in monocytes and endothelial cells: Thromboxane A2 as a new player, Vascul. Pharmacol, vol.62, pp.57-62, 2014. ,
Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy, Cancer Res, vol.71, pp.6492-6502, 2011. ,
Tissue factor in cancer progression and angiogenesis, Thromb. Res, vol.125, pp.36-38, 2010. ,
A. uPA/PAI-1 ratios distinguish benign prostatic hyperplasia and prostate cancer, J. Cancer Res. Clin. Oncol, vol.139, pp.1221-1228, 2013. ,
Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance, Oncol. Rep, vol.29, pp.637-645, 2013. ,
Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis, Surgery, vol.158, pp.1704-1713, 2015. ,
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer-Relationship with clinical outcome, Anticancer Res, vol.34, pp.1153-1161, 2014. ,
Molecular basis for the relationship between thrombosis and cancer, Thromb. Res, vol.102, pp.215-224, 2001. ,
Involvement of platelet-derived microparticles in tumor progression and thrombosis, Semin. Oncol, vol.41, pp.346-358, 2014. ,
The biological significance of the thromboplastic protein of blood, J. Biol. Chem, vol.166, pp.189-197, 1946. ,
Microparticles as Biomarkers of Blood Coagulation in Cancer, Biomark. Cancer, vol.7, pp.51-56, 2015. ,
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients, Blood, vol.122, pp.1873-1880, 2013. ,
Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer, Thromb. Haemost, vol.97, pp.119-123, 2007. ,
Circulating tumour-derived microvesicles in plasma of gastric cancer patients, Cancer Immunol. Immunother, vol.59, pp.841-850, 2010. ,
Pancreatic cancer cell and microparticle procoagulant surface characterization: Involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine, Blood Coagul. Fibrinolysis, vol.22, pp.680-687, 2011. ,
Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer, PLoS ONE, vol.7, 2012. ,
Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles, Cancer Res, vol.64, pp.7045-7049, 2004. ,
Her2/neu-, BCRP-and Hsp27-positive microparticles in breast cancer patients, Anticancer Res, vol.30, pp.1707-1712, 2010. ,
The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study, Int. J. Cancer, vol.138, pp.939-948, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01460678
Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice, J. Thromb. Haemost, vol.13, pp.1310-1319, 2015. ,
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size, J. Thromb. Haemost, vol.15, pp.2208-2217, 2017. ,
NETosis: A new factor in tumor progression and cancer-associated thrombosis, Semin. Thromb. Hemost, vol.40, pp.277-283, 2014. ,
Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity, Thromb. Haemost, vol.110, pp.966-976, 2013. ,
Tumor-Derived Exosomes Induce the Formation of Neutrophil Extracellular Traps: Implications For The Establishment of Cancer-Associated Thrombosis ,
Inhibition of in vivo tumour growth by the blocking of host alpha(v)beta3 and alphaII(b)beta3 integrins, Anticancer Res, vol.29, pp.131-137, 2009. ,
Activated tumor cell integrin ?v?3 cooperates with platelets to promote extravasation and metastasis from the blood stream, Thromb. Res, vol.140, pp.27-36, 2016. ,
Platelet integrin ?6?1 controls lung metastasis through direct binding to cancer cell-derived ADAM9, JCI Insight, vol.1, 2016. ,
P-selectin deficiency attenuates tumor growth and metastasis, vol.95, pp.9325-9330, 1998. ,
P-selectin-mediated platelet adhesion promotes tumor growth, Oncotarget, vol.6, pp.6584-6596, 2015. ,
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis, Arch. Immunol. Ther. Exp, vol.54, pp.75-84, 2006. ,
Circulating activated platelets in myeloproliferative disorders, Thromb. Res, vol.61, pp.271-278, 1991. ,
Tumor-cell-induced platelet aggregation is a glycoprotein-dependent and lipoxygenase-associated process, Int. J. Cancer, vol.39, pp.760-763, 1987. ,
Inhibition of Human Tumor Cell Induced Platelet Aggregation by Antibodies to Platelet Glycoproteins lb and llb/llla, Proc. Soc. Exp. Biol. Med, vol.186, pp.378-383, 1987. ,
Platelet glycoprotein Ib? supports experimental lung metastasis, vol.104, pp.9024-9028, 2007. ,
Characterization of tumor-induced platelet aggregation: The role of immunorelated GPIb and GPIIb IIIa expression by MCF-7 breast cancer cells, Thromb. Res, vol.79, pp.261-274, 1995. ,
Inhibition of Platelet GPIb? and Promotion of Melanoma Metastasis, J. Investig. Dermatol, vol.130, pp.576-586, 2010. ,
The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis, J. Biochem, vol.152, pp.407-413, 2012. ,
Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma, vol.26, pp.195-200, 2005. ,
Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis, Int. J. Cancer, vol.134, pp.2605-2614, 2014. ,
Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors, J. Biol. Chem, vol.278, pp.51599-51605, 2003. ,
Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2, PLoS ONE, vol.8, 2013. ,
Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: Subject-dependent variation in thrombogram characteristics, J. Thromb. Haemost, vol.2, pp.476-484, 2004. ,
Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas, J. Clin. Investig, vol.112, pp.853-862, 2003. ,
NETs and cancer, Thromb. Res, vol.164, pp.148-152, 2018. ,
Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury, J. Clin. Investig, vol.122, pp.2661-2671, 2012. ,
Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin, Br. J. Pharmacol, vol.170, pp.255-265, 2013. ,
Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation, Blood, vol.123, pp.2573-2584, 2014. ,
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo, J. Exp. Med, vol.209, pp.819-835, 2012. ,
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps, J. Thromb. Haemost, vol.12, pp.2074-2088, 2014. ,
Novel Anti-bacterial Activities of ?-defensin 1 in Human Platelets: Suppression of Pathogen Growth and Signaling of Neutrophil Extracellular Trap Formation, PLOS Pathog, 2011. ,
Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets, J. Leuk. Biol, vol.99, pp.153-162, 2016. ,
Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity, Blood Coagul. Fibrinolysis, vol.13, pp.505-512, 2002. ,
Significant downregulation of platelet gene expression in metastatic lung cancer, Clin. Transl. Sci, vol.3, pp.227-232, 2010. ,
Blood platelets contain tumor-derived RNA biomarkers, Blood, vol.118, pp.3680-3683, 2011. ,
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics, Cancer Cell, vol.28, pp.666-676, 2015. ,
Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets, Cell, vol.122, pp.379-391, 2005. ,
Circular RNA enrichment in platelets is a signature of transcriptome degradation, Blood, vol.127, pp.1-11, 2016. ,
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes, Blood, vol.118, pp.101-111, 2011. ,
A tour through the transcriptional landscape of platelets, Blood, vol.124, pp.493-502, 2014. ,
Existence of a microRNA pathway in anucleate platelets, Nat. Struct. Mol. Biol, vol.16, pp.961-966, 2009. ,
The complex transcriptional landscape of the anucleate human platelet, BMC Genom, vol.14, 2013. ,
The repertoire and features of human platelet microRNAs, PLoS ONE, vol.7, 2012. ,
In vitro DNA and RNA synthesis by human platelets, Biochim. Biophys. Acta, vol.425, pp.41-48, 1976. ,
Stable messenger RNA in the synthesis of contractile protein in human platelets, Biochim. Biophys. Acta, vol.145, pp.188-190, 1967. ,
Lipopolysaccharide signaling without a nucleus: Kinase cascades stimulate platelet shedding of proinflammatory IL-1?-rich microparticles, J. Immunol, vol.186, pp.5489-5496, 2011. ,
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets, J. Exp. Med, vol.203, pp.2433-2440, 2006. ,
Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets, Thromb. Haemost, vol.85, pp.142-151, 2001. ,
The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing, Hum. Mol. Genet, vol.19, pp.1153-1164, 2010. ,
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer, Oncotarget, vol.7, pp.1066-1075, 2015. ,
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets, Cancer Cell, vol.32, pp.238-252, 2017. ,
Long non-coding RNA GAS5 inhibits tumorigenesis via miR-137 in melanoma, Am. J. Transl. Res, vol.9, pp.1509-1520, 2017. ,
LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1, Mol. Cancer Res, vol.15, pp.789-799, 2017. ,
LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis, Cancer Manag. Res, vol.10, pp.1449-1459, 2018. ,
Association of MicroRNAs and YRNAs With Platelet FunctionNovelty and Significance, Circ. Res, vol.118, pp.420-432, 2016. ,
Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression, Blood, vol.121, pp.3908-3917, 2013. ,
The human platelet: Strong transcriptome correlations among individuals associate weakly with the platelet proteome, Biol. Direct, vol.9, issue.3, 2014. ,
Integration of proteomics and genomics in platelets: A profile of platelet proteins and platelet-specific genes, Mol. Cell Proteomics, vol.3, pp.133-144, 2004. ,
The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways, Blood, vol.120, pp.73-82, 2012. ,
Coordinate expression of transcripts and proteins in platelets, Blood, vol.121, pp.5255-5256, 2013. ,
The endocytic adaptor protein Disabled-2 is required for cellular uptake of fibrinogen, Biochim. Biophys. Acta Mol. Cell Res, vol.1823, pp.1778-1788, 2012. ,
Cellubrevin/vesicle-associated membrane protein-3-Mediated endocytosis and trafficking regulate platelet functions, vol.130, pp.2872-2883, 2017. ,
Platelets actively sequester angiogenesis regulators, Blood, vol.113, pp.2835-2842, 2009. ,
PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy, Oncotarget, vol.9, pp.27460-27470, 2018. ,
Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials, Lancet, vol.379, pp.1591-1601, 2012. ,
Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells, Oncotarget, vol.7, pp.32462-32477, 2016. ,
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer, JAMA Oncol, vol.2, pp.762-769, 2016. ,
Aspirin, platelets, and cancer: The point of view of the internist, Eur. J. Intern. Med, vol.34, pp.11-20, 2016. ,
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer, Int. J. Cancer, vol.136, pp.234-240, 2015. ,
Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo, Int. J. Cancer, vol.136, pp.462-475, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01773064
Clopidogrel in a combined therapy with anticancer drugs-Effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models, PLoS ONE, vol.12, 2017. ,
Platelet Inhibition with Prasugrel and Increased Cancer Risks: Potential Causes and Implications, Am. J. Med, vol.122, pp.407-408, 2009. ,
The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence, Am. J. Med, vol.130, pp.826-832, 2017. ,
Clopidogrel Treatment Is Associated with a Decrease in Cancer Incidence, Blood, vol.126, p.1124, 2015. ,
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E, Nat. Med, vol.9, pp.61-67, 2003. ,
Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/-mice, Thromb. Haemost, vol.98, pp.1108-1113, 2007. ,
Platelets Contribute to Allograft Rejection through Glutamate Receptor Signaling, J. Immunol, vol.185, pp.6999-7006, 2010. ,
Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154, J. Clin. Investig, vol.116, pp.769-774, 2006. ,
Presence of intratumoral platelets is associated with tumor vessel structure and metastasis, BMC Cancer, vol.14, 2014. ,
Platelet-cytokine Complex Suppresses Tumour Growth by Exploiting Intratumoural Thrombin-dependent, Platelet Aggregation. Sci. Rep, 2016. ,
Genetic engineering of platelets to neutralize circulating tumor cells, J. Control. Release, vol.228, 2016. ,